Rivaroxaban versus Low Molecular Weight Heparin for Cancer-Associated Venous Thromboembolism - A Systematic Review and Meta-Analysis
Favorite
Share
More Options
18

Open in WPS to view all 18 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
